meningococcal vaccine
- Generic Name
- meningococcal vaccine
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2018-06-19
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 215
- Registration Number
- NCT03562377
- Locations
- 🇨🇦
LEO Pharma Investigational Site, Verdun, Quebec, Canada
🇺🇸Leo Pharma Investigational Site, Spokane, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath